ABPI Patient Advisory Council Report

As a collective of charity CEOs working collaboratively with the ABPI, we have long been aware of the human cost of NHS decisions and processes that fail to ensure equitable access and timely uptake of proven innovative treatments. This is a problem that compounds already deep-seated health inequalities across the UK.

This human cost can be significant, and our report illustrates the impact that the inequitable uptake of innovative treatments can have on patients, their families and the health professionals who care for them.

More positively, our report also sets out practical examples of how to minimise this inequity and ameliorate patient outcomes and care.